Assessing the utility of a community pharmacy refill record as a measure of adherence and viral load response in patients infected with human immunodeficiency virus

Pharmacotherapy

Volumn 25, Issue 6, 2005, Pages 790-796

  Inciardi, John F ^a   Leeds, Andrew L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b School of Pharmacy   (United States)

Author keywords

AIDS; Antiretroviral drugs; Drug compliance; HIV; Pharmacy refill record; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; ASIA; CAUCASIAN; COMMUNITY PHARMACY REFILL RECORD; DIAGNOSTIC VALUE; DRUG RESPONSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PHARMACY; PREDICTION; PRESCRIPTION; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; COMMUNITY PHARMACY SERVICES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RECORDS; RETROSPECTIVE STUDIES; ROC CURVE; VIRAL LOAD;

EID: 19444377579     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.2005.25.6.790     Document Type: Review

References (16)

1. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adlicrence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001;15(9):1181-3.
2. Cinti SK. Adherence to antiretrovirals in HIV disease. AIDS Read 2000;10(12):709-17.
3. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS 2003;17(4):169-77.
4. Bangsberg DR, Hecht FM, Clague H, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr 2001;26(5):435-42.
5. Miller LG, Liu H, Hays RD, et al. How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med 2002;17(1):1-11.
6. Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS 2002;16(13):1835-7.
7. Kimmerling M, Wagner G, Ghosh-Dastidar B. Factors associated with accurate self-reported adherence to HIV antiretrovirals. Int J STD AIDS 2003;14(4):281-4.
8. Wagner GJ, Rabkin JG. Measuring medication adherence: are missed closes reported more accurately then perfect adherence? AIDS Care 2000;12(4):405-8.
9. Paes AH, Bakker A, Soe-Agnie CJ. Measurement of patient compliance. Pharm World Sci 1998;20(2):73-7.
10. Mathews WC, Mar-Tang M, Ballard C, et al. Prevalence, predictors, and outcomes of early adherence after starting or changing aniiretroviral therapy. AIDS Patient Care STDS 2002;16(4):157-72.
11. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50(1):105-16.
12. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records: description and validation. Med Care 1988;26(8):814-23.
13. Vanhove GF, Schapiro JM, Winters MA, Merigan TC, Blaschke TF. Patiem compliance and drug failure in protease inhibitor monotherapy. JAMA 1996;276(24):1955-6.
14. Cleveland, WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74:829-36.
15. Miller LG, Golin CE, Liu H, et al. No evidence of an association between transient HIV viremia ("blips") and lower adherence to the antirelroviral medication regimen. J Infect Dis 2004;189(8):1487-96.
16. Bartlett JG. Panel on clinical practices issues, revised adult ART guidelines. Hopkins HIV Report 2003;15(5):8-9.